FREQUENCY THERAPEUTICS, INC. (FREQ) News

FREQUENCY THERAPEUTICS, INC. (FREQ): $14.98

0.84 (+5.94%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add FREQ to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#247 of 381

in industry

Filter FREQ News Items

FREQ News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest FREQ News From Around the Web

Below are the latest news stories about FREQUENCY THERAPEUTICS INC that investors may wish to consider to help them evaluate FREQ as an investment opportunity.

Frequency Therapeutics Provides Business Updates and Second Quarter 2023 Financial Results

LEXINGTON, Mass., August 10, 2023--Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023.

Yahoo | August 10, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning!

William White on InvestorPlace | August 1, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!

William White on InvestorPlace | July 17, 2023

Frequency (FREQ) Up 77% on Merger Deal With Korro Bio

Post-merger, Frequency (FREQ) focuses on advancing RNA editing programs. This combined entity is set to operate under the name Korro Bio, which will apply to trade on the NASDAQ under the ticker symbol KRRO.

Yahoo | July 17, 2023

Why Is Ainos (AIMD) Stock Up 82% Today?

Ainos (AIMD) stock is on the rise Friday with heavy trading despite a lack of news from the medical technologies company.

William White on InvestorPlace | July 14, 2023

Why Is Frequency Therapeutics (FREQ) Stock Up 44% Today?

Frequency Therapeutics (FREQ) stock is rocketing higher on Friday with heavy trading following news that it will combine with Korro Bio.

William White on InvestorPlace | July 14, 2023

Why Is Theseus Pharmaceuticals (THRX) Stock Down 68% Today?

Theseus Pharmaceuticals (THRX) stock is falling hard on Friday after the company announced poor results from a Phase 1/2 clinical trial.

William White on InvestorPlace | July 14, 2023

Why Is Leslies (LESL) Stock Down 36% Today?

Leslies (LESL) stock is falling on Friday after the company released its preliminary earnings report for the third quarter of 2023.

William White on InvestorPlace | July 14, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time to start the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday!

William White on InvestorPlace | July 14, 2023

Why Are Frequency Therapeutics Shares Surging Today

Korro Bio Inc and Frequency Therapeutics Inc (NASDAQ: FREQ) announced an all-stock merger transaction. Under the merger agreement's terms, stockholders of Korro Bio will receive newly issued shares of Frequency Therapeutics. Frequency Therapeutics has discontinued developing its remyelination program for Multiple Sclerosis as it explores strategic alternatives for the program. Suppose Frequency Therapeutics has not otherwise monetized its remyelination program before the closing of the proposed

Yahoo | July 14, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!